ImmunoPrecise subsidiary expands B cell Select platform

By The Science Advisory Board staff writers

September 22, 2020 -- IPA Europe, a subsidiary of ImmunoPrecise Antibodies, has expanded its foundational B cell Select platform for seamless integration into ImmunoPrecise's optimization and antibody developability profiling workflow.

With substantial investments, IPA Europe developed a second-generation platform that enables multispecies, target-interaction-based single B cell selection technology and subsequent single cell cloning for accelerated identification of comprehensive panels of diverse lead therapeutic antibodies.

The B cell Select platform enables interrogation of isolated B cells to analyze full organism antibody repertoires. The species independent platform can develop a range of antibodies, including any protein class, complex therapeutic target, post-translation modifications, and small molecules. The system generates monoclonal antibodies for B cell selection to accelerate the rate of the antibody discovery process.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here